Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Protara Therapeutics Inc
Swot
Protara Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Protara Therapeutics Inc has 14 Strengths, 7 Weaknesses, 2 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(14)
Weakness
(7)
Opportunity
(2)
Threats
(2)
Others
(1)
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
MACD crossed above zero line previous end of day
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)
Volume Shockers
High Volume, High Gain
Highest Recovery from 52 Week Low
Promoter decreasing their shareholding
Negative profit growth, promoters decreasing shareholding QoQ
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mutual Funds Decreased Shareholding in Past Month
Institutions decreased their shareholding last quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
